In assessing RFS according to each tumor marker, the abnormal β-hCG, CA19-9, CA125, and CEA groups had significantly worse RFS than their respective normal groups (P=0.003, P=0.012, P=0.042, and P=0.031, respectively; Figure 1). This evidence concerns the gene MUC16 and neoplasm.